[1]. Katzan, I.L., et al., The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology, 2003. 60(4): p. 620-5.
[2]. Smith, C.J., et al., Diagnosis of Stroke-Associated Pneumonia. Stroke, 2015. 46(8): p. 2335-2340.
[3]. Cugy, E. and I. Sibon, Stroke-Associated Pneumonia Risk Score: Validity in a French Stroke Unit. Journal of Stroke and Cerebrovascular Diseases, 2017. 26(1): p. 225-229.
[4]. Katzan, I.L., et al., The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology, 2003. 60(4): p. 620-5.
[5]. Langhorne, P., et al., Medical complications after stroke: a multicenter study. Stroke, 2000. 31(6): p. 1223-9.
[6]. Ji, R., et al., Novel risk score to predict pneumonia after acute ischemic stroke. Stroke, 2013. 44(5): p. 1303-9.
[7]. Hoffmann, S., et al., Development of a Clinical Score (A2DS2) to Predict Pneumonia in Acute Ischemic Stroke. Stroke, 2012. 43(10): p. 2617-2623.
[8]. Zhang, X., et al., The A2DS2 Score as a Predictor of Pneumonia and In-Hospital Death after Acute Ischemic Stroke in Chinese Populations. PLOS ONE, 2016. 11(3): p. e0150298.
[9]. Li, Y., et al., External validation of the A2DS2 score to predict stroke-associated pneumonia in a Chinese population: a prospective cohort study. PLoS One, 2014. 9(10): p. e109665.
[10]. Lu, Y., et al., Serum iron and A(2)DS(2) score in stroke-associated pneumonia. International journal of clinical and experimental medicine, 2015. 8(4): p. 6163.
[11]. Ramirez-Moreno, J.M., et al., External validation of the A2SD2 and ISAN scales for predicting infectious respiratory complications of ischaemic stroke. Neurologia, 2016.
[12]. Zapata-Arriaza, E., et al., External Validation of the ISAN, A2DS2, and AIS-APS Scores for Predicting Stroke-Associated Pneumonia. J Stroke Cerebrovasc Dis, 2017.
[13]. Smith, C.J., et al., Can a Novel Clinical Risk Score Improve Pneumonia Prediction in Acute Stroke Care? A UK Multicenter Cohort Study. Journal of the American Heart Association, 2014. 4(1): p. e001307-e001307.
[14]. Jeon, C.Y., et al., The role of pre-operative and post-operative glucose control in surgical-site infections and mortality. PLoS One, 2012. 7(9): p. e45616.
[15]. Ata, A., et al., Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg, 2010. 145(9): p. 858-64.
[16]. 大西幸子, 孙启良与赵峻, 摄食·吞咽障碍康复实用技术. 中国医药科技出版社, 2000.
[17]. Giselle Mann, B.P.G.D., M.F.F.E. Graeme J. Hankey and M.F.F.F. David Cameron, Swallowing Function After Stroke. Stroke, 1999(30): p. 744-748.
[18]. Chamorro, A., et al., The immunology of acute stroke. Nat Rev Neurol, 2012. 8(7): p. 401-10.
[19]. Marklund, N., et al., Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med, 2004. 256(1): p. 15-21.
[20]. Bernik, T.R., et al., Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med, 2002. 195(6): p. 781-8.
[21]. Tuosto, L., et al., Analysis of susceptibility of mature human T lymphocytes to dexamethasone-induced apoptosis. Eur J Immunol, 1994. 24(5): p. 1061-5.
[22]. Rayfield, E.J., et al., Infection and diabetes: the case for glucose control. Am J Med, 1982. 72(3): p. 439-50.
[23]. Delamaire, M., et al., Impaired leucocyte functions in diabetic patients. Diabet Med, 1997. 14(1): p. 29-34.
[24]. Obiako, O.R., A. Ogunniyi and S.K. Oparah, Prognosis and outcome of acute stroke in the University College Hospital Ibadan, Nigeria. Nigerian Journal of Clinical Practice, 2011. 14(3): p. 359.
[25]. Dziedzic, T., et al., Association between hyperglycemia, heart failure and mortality in stroke patients. European Journal of Neurology, 2009. 16(2): p. 251-256.
[26]. Hirata, Y., et al., Association of hyperglycemia on admission and during hospitalization with mortality in diabetic patients admitted for pneumonia. Internal Medicine, 2013. 52: p. 2431-2438.
[27]. Li, W.A., et al., Hyperglycemia in stroke and possible treatments. Neurological Research, 2013. 5(35): p. 479-491.